Go Pro

DRI Healthcare Trust (DHT.UN) Competitors

DRI Healthcare Trust logo
C$17.39 +0.05 (+0.29%)
As of 04:00 PM Eastern

DHT.UN vs. BHC, MJN, CRON, CARA, and THCX

Should you buy DRI Healthcare Trust stock or one of its competitors? DRI Healthcare Trust's main competitors and comparable companies include Bausch Health Companies (BHC), Cronos Group (MJN), Cronos Group (CRON), Cara Operations (CARA), and Hydropothecary (THCX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does DRI Healthcare Trust compare to Bausch Health Companies?

DRI Healthcare Trust (TSE:DHT.UN) and Bausch Health Companies (TSE:BHC) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

DRI Healthcare Trust has a beta of 0.365327, meaning that its share price is 63% less volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.707626, meaning that its share price is 29% less volatile than the broader market.

DRI Healthcare Trust has a net margin of 5.02% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat DRI Healthcare Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Bausch Health Companies -12.02%87.57%4.16%

DRI Healthcare Trust currently has a consensus target price of C$25.20, suggesting a potential upside of 44.91%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts clearly believe DRI Healthcare Trust is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Bausch Health Companies
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

DRI Healthcare Trust has higher earnings, but lower revenue than Bausch Health Companies. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$172.34M5.55C$9.73M-C$0.80N/A
Bausch Health CompaniesC$10.85B0.31-C$125.65M-C$2.94N/A

0.8% of DRI Healthcare Trust shares are owned by institutional investors. Comparatively, 9.6% of Bausch Health Companies shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Comparatively, 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, DRI Healthcare Trust had 1 more articles in the media than Bausch Health Companies. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 1 mentions for Bausch Health Companies. DRI Healthcare Trust's average media sentiment score of 1.49 beat Bausch Health Companies' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DRI Healthcare Trust
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bausch Health Companies
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

DRI Healthcare Trust beats Bausch Health Companies on 11 of the 17 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cronos Group?

DRI Healthcare Trust (TSE:DHT.UN) and Cronos Group (CVE:MJN) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Cronos Group. DRI Healthcare Trust's average media sentiment score of 1.49 beat Cronos Group's score of 0.51 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Cronos Group Positive

DRI Healthcare Trust has higher revenue and earnings than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$172.34M5.55C$9.73M-C$0.80N/A
Cronos GroupN/AN/AN/AN/AN/A

DRI Healthcare Trust presently has a consensus price target of C$25.20, indicating a potential upside of 44.91%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, equities analysts plainly believe DRI Healthcare Trust is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

0.8% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

DRI Healthcare Trust pays an annual dividend of C$0.42 per share and has a dividend yield of 2.4%. Cronos Group pays an annual dividend of C$1.65 per share and has a dividend yield of 13.6%. DRI Healthcare Trust pays out -52.5% of its earnings in the form of a dividend.

DRI Healthcare Trust has a net margin of 5.02% compared to Cronos Group's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Cronos Group N/A N/A N/A

Summary

DRI Healthcare Trust beats Cronos Group on 13 of the 14 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cronos Group?

Cronos Group (TSE:CRON) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Cronos Group. DRI Healthcare Trust's average media sentiment score of 1.49 beat Cronos Group's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Cronos Group Neutral
DRI Healthcare Trust Positive

DRI Healthcare Trust has lower revenue, but higher earnings than Cronos Group. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$179.09M8.99-C$32.78MC$0.1923.00
DRI Healthcare TrustC$172.34M5.55C$9.73M-C$0.80N/A

Cronos Group currently has a consensus target price of C$4.92, suggesting a potential upside of 12.51%. DRI Healthcare Trust has a consensus target price of C$25.20, suggesting a potential upside of 44.91%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts plainly believe DRI Healthcare Trust is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

Cronos Group has a net margin of 38.95% compared to DRI Healthcare Trust's net margin of 5.02%. Cronos Group's return on equity of 6.46% beat DRI Healthcare Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group38.95% 6.46% -3.73%
DRI Healthcare Trust 5.02%2.06%4.22%

4.2% of Cronos Group shares are held by institutional investors. Comparatively, 0.8% of DRI Healthcare Trust shares are held by institutional investors. 46.4% of Cronos Group shares are held by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cronos Group has a beta of 1.29991, meaning that its stock price is 30% more volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.365327, meaning that its stock price is 63% less volatile than the broader market.

Summary

Cronos Group beats DRI Healthcare Trust on 9 of the 17 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Cara Operations?

DRI Healthcare Trust (TSE:DHT.UN) and Cara Operations (TSE:CARA) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

DRI Healthcare Trust has a net margin of 5.02% compared to Cara Operations' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Cara Operations' return on equity.

Company Net Margins Return on Equity Return on Assets
DRI Healthcare Trust5.02% 2.06% 4.22%
Cara Operations N/A N/A N/A

0.8% of DRI Healthcare Trust shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

DRI Healthcare Trust pays an annual dividend of C$0.42 per share and has a dividend yield of 2.4%. Cara Operations pays an annual dividend of C$0.41 per share. DRI Healthcare Trust pays out -52.5% of its earnings in the form of a dividend.

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Cara Operations. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Cara Operations. DRI Healthcare Trust's average media sentiment score of 1.49 beat Cara Operations' score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the media.

Company Overall Sentiment
DRI Healthcare Trust Positive
Cara Operations Neutral

DRI Healthcare Trust presently has a consensus price target of C$25.20, suggesting a potential upside of 44.91%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, analysts plainly believe DRI Healthcare Trust is more favorable than Cara Operations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Cara Operations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

DRI Healthcare Trust has higher revenue and earnings than Cara Operations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DRI Healthcare TrustC$172.34M5.55C$9.73M-C$0.80N/A
Cara OperationsN/AN/AN/AN/AN/A

Summary

DRI Healthcare Trust beats Cara Operations on 14 of the 14 factors compared between the two stocks.

How does DRI Healthcare Trust compare to Hydropothecary?

Hydropothecary (CVE:THCX) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

DRI Healthcare Trust has higher revenue and earnings than Hydropothecary.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HydropothecaryN/AN/AN/AN/AN/A
DRI Healthcare TrustC$172.34M5.55C$9.73M-C$0.80N/A

0.8% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

DRI Healthcare Trust has a net margin of 5.02% compared to Hydropothecary's net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Hydropothecary's return on equity.

Company Net Margins Return on Equity Return on Assets
HydropothecaryN/A N/A N/A
DRI Healthcare Trust 5.02%2.06%4.22%

In the previous week, DRI Healthcare Trust had 2 more articles in the media than Hydropothecary. MarketBeat recorded 2 mentions for DRI Healthcare Trust and 0 mentions for Hydropothecary. DRI Healthcare Trust's average media sentiment score of 1.49 beat Hydropothecary's score of 0.00 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Overall Sentiment
Hydropothecary Neutral
DRI Healthcare Trust Positive

DRI Healthcare Trust has a consensus price target of C$25.20, suggesting a potential upside of 44.91%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, analysts clearly believe DRI Healthcare Trust is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

Summary

DRI Healthcare Trust beats Hydropothecary on 12 of the 12 factors compared between the two stocks.

Get DRI Healthcare Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHT.UN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHT.UN vs. The Competition

MetricDRI Healthcare TrustPharmaceuticals IndustryHealthcare SectorTSE Exchange
Market CapC$955.81MC$11.86BC$7.04BC$12.38B
Dividend Yield3.45%2.59%2.54%6.25%
P/E Ratio-21.74784.68271.1539.79
Price / Sales5.55761.30625.529.91
Price / CashN/A15.1828.9282.29
Price / Book1.8711.0010.924.72
Net IncomeC$9.73MC$2.81BC$3.48BC$299.09M
7 Day Performance-2.36%-0.12%-0.03%0.89%
1 Month Performance-1.36%4.34%3.01%0.54%
1 Year Performance18.06%7.58%22.73%26.87%

DRI Healthcare Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHT.UN
DRI Healthcare Trust
2.7212 of 5 stars
C$17.39
+0.3%
C$25.20
+44.9%
+18.9%C$955.81MC$172.34MN/AN/A
BHC
Bausch Health Companies
0.3368 of 5 stars
C$8.78
flat
N/A-11.0%C$3.28BC$10.85BN/A19,900
MJN
Cronos Group
N/AC$12.15
-1.9%
N/A+0.0%C$1.73BN/AN/A7,600
CRON
Cronos Group
1.8705 of 5 stars
C$4.68
flat
C$4.92
+5.1%
+29.3%C$1.72BC$179.09M24.63450
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/AN/A80

Related Companies and Tools


This page (TSE:DHT.UN) was last updated on 9/8/2026 by MarketBeat.com Staff.
From Our Partners